Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C72H112O48S8 |
Molecular Weight | 2002.151 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 40 / 40 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12O[C@H](CSCCC(O)=O)[C@@H](O[C@@]3([H])O[C@H](CSCCC(O)=O)[C@@H](O[C@@]4([H])O[C@H](CSCCC(O)=O)[C@@H](O[C@@]5([H])O[C@H](CSCCC(O)=O)[C@@H](O[C@@]6([H])O[C@H](CSCCC(O)=O)[C@@]([H])(O[C@H]7O[C@H](CSCCC(O)=O)[C@@]([H])(O[C@H]8O[C@H](CSCCC(O)=O)[C@@]([H])(O[C@H]9O[C@H](CSCCC(O)=O)[C@@H](O1)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O
InChI
InChIKey=WHRODDIHRRDWEW-VTHZAVIASA-N
InChI=1S/C72H112O48S8/c73-33(74)1-9-121-17-25-57-41(89)49(97)65(105-25)114-58-26(18-122-10-2-34(75)76)107-67(51(99)43(58)91)116-60-28(20-124-12-4-36(79)80)109-69(53(101)45(60)93)118-62-30(22-126-14-6-38(83)84)111-71(55(103)47(62)95)120-64-32(24-128-16-8-40(87)88)112-72(56(104)48(64)96)119-63-31(23-127-15-7-39(85)86)110-70(54(102)46(63)94)117-61-29(21-125-13-5-37(81)82)108-68(52(100)44(61)92)115-59-27(19-123-11-3-35(77)78)106-66(113-57)50(98)42(59)90/h25-32,41-72,89-104H,1-24H2,(H,73,74)(H,75,76)(H,77,78)(H,79,80)(H,81,82)(H,83,84)(H,85,86)(H,87,88)/t25-,26-,27-,28-,29-,30-,31-,32-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-/m1/s1
Molecular Formula | C72H112O48S8 |
Molecular Weight | 2002.151 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 40 / 40 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:32:00 UTC 2023
by
admin
on
Fri Dec 15 16:32:00 UTC 2023
|
Record UNII |
361LPM2T56
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QV03AB35
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
||
|
WHO-ATC |
V03AB35
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
||
|
NCI_THESAURUS |
C26170
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C80629
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
1726988
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | RxNorm | ||
|
343306-71-8
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
6918585
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
SUGAMMADEX
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
N0000168522
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | gamma-Cyclodextrins [Chemical/Ingredient] | ||
|
361LPM2T56
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
SUB26695
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
C453980
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
4233
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
m10289
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID90895043
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
DB06206
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
8528
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
100000089639
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
90953
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
CHEMBL2111107
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
CD-10
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
Sugammadex
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY | |||
|
361LPM2T56
Created by
admin on Fri Dec 15 16:32:00 UTC 2023 , Edited by admin on Fri Dec 15 16:32:00 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
LIGAND->BINDER |
|
||
|
EXCRETED UNCHANGED |
On an average, more than 90% of sugammadex was recovered in urine within 24 hours. Other PK studies also showed that 65-97% of the dose was recovered in urine. The differences in urine excretion percentage may be partly due to error associated with urine sample collection.
URINE
|
||
|
LIGAND->BINDER |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||